Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-01-25 @ 4:56 AM
Study NCT ID:
NCT00001520
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
960122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None